We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.2B
AUM Growth
+$921M
Cap. Flow
+$201M
Cap. Flow %
1.79%
Top 10 Hldgs %
19.59%
Holding
393
New
24
Increased
178
Reduced
115
Closed
8

Top Buys

Rank Stock Value
1
CHE icon
Chemed
CHE
+$33.2M
2
TEL icon
TE Connectivity
TEL
+$33.1M
3
HELE icon
Helen of Troy
HELE
+$29.2M
4
COLB icon
Columbia Banking Systems
COLB
+$25M
5
CVCO icon
Cavco Industries
CVCO
+$19M

Top Sells

Rank Stock Value
1
CMD
Cantel Medical Corporation
CMD
+$52.2M
2
BRKR icon
Bruker
BRKR
+$42.9M
3
WSM icon
Williams-Sonoma
WSM
+$40.5M
4
MMM icon
3M
MMM
+$34.1M
5
SBNY
Signature Bank
SBNY
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 19.74%
2 Financials 16.42%
3 Healthcare 14.76%
4 Industrials 14.05%
5 Consumer Discretionary 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEU icon
301
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
$757K 0.01%
11,945
-75
-0.6% -$4.75K
ROP icon
302
Roper Technologies
ROP
$40.4B
$755K 0.01%
1,606
+220
+16% +$97.3K
AVGO icon
303
Broadcom
AVGO
$1.76T
$740K 0.01%
15,510
– –
SO icon
304
Southern Company
SO
$108B
$737K 0.01%
12,175
+3,275
+37% +$209K
REGN icon
305
Regeneron Pharmaceuticals
REGN
$72.9B
$726K 0.01%
1,300
– –
WMT icon
306
Walmart Inc
WMT
$909B
$696K 0.01%
14,802
+1,500
+11% +$69.9K
UL icon
307
Unilever
UL
$142B
$681K 0.01%
10,346
– –
TM icon
308
Toyota
TM
$228B
$678K 0.01%
3,880
+1,950
+101% +$320K
EWJ icon
309
iShares MSCI Japan ETF
EWJ
$21.2B
$662K 0.01%
9,800
– –
IWB icon
310
iShares Russell 1000 ETF
IWB
$47.1B
$655K 0.01%
2,705
– –
ORA icon
311
Ormat Technologies
ORA
$5.8B
$651K 0.01%
9,363
+1,710
+22% +$122K
MGA icon
312
Magna International
MGA
$18.8B
$645K 0.01%
6,967
+2,400
+53% +$229K
BNS icon
313
Scotiabank
BNS
$105B
$633K 0.01%
9,725
– –
FISV
314
Fiserv Inc
FISV
$29.7B
$628K 0.01%
5,878
+3,800
+183% +$442K
DFAC icon
315
Dimensional US Core Equity 2 ETF
DFAC
$47B
$619K 0.01%
+22,937
New +$610K
QUAL icon
316
iShares MSCI USA Quality Factor ETF
QUAL
$45.7B
$602K 0.01%
4,527
– –
WBA
317
DELISTED
Walgreens Boots Alliance
WBA
$598K 0.01%
11,362
– –
DFS
318
DELISTED
Discover Financial Services
DFS
$574K 0.01%
4,856
-2,000
-29% -$226K
EPP icon
319
iShares MSCI Pacific ex Japan ETF
EPP
$2.21B
$553K ﹤0.01%
10,700
– –
BLK icon
320
Blackrock
BLK
$167B
$547K ﹤0.01%
625
– –
NOC icon
321
Northrop Grumman
NOC
$76B
$547K ﹤0.01%
1,506
– –
CBT icon
322
Cabot Corp
CBT
$4.72B
$521K ﹤0.01%
9,159
+1,486
+19% +$87.3K
TMO icon
323
Thermo Fisher Scientific
TMO
$214B
$521K ﹤0.01%
1,033
– –
BAX icon
324
Baxter International
BAX
$12.8B
$517K ﹤0.01%
6,421
– –
VCSH icon
325
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$517K ﹤0.01%
6,247
– –
11 12
13
14 15

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q2 2021 Portfolio in Review

As of Q2 2021, Boston Trust Walden held 393 positions worth $11.2B, up 8.9% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2021 filing shows 24 new, 178 increased, 115 reduced and 8 closed positions. Its largest new stake was Helen of Troy: 132,720 shares worth $30.3M. The largest sale was Cantel Medical Corporation, an estimated $52.2M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2021 buy was Helen of Troy: 132,720 shares worth $30.3M.
  • Boston Trust Walden added most to Chemed in Q2 2021, an estimated $33.2M increase.
  • Boston Trust Walden's biggest Q2 2021 reduction was Bruker, cutting an estimated $42.9M.
  • Boston Trust Walden fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $52.2M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $11.2B portfolio in Q2 2021.
  • Boston Trust Walden opened 24 new positions and closed 8 in Q2 2021.
  • Boston Trust Walden's portfolio value rose 8.9% quarter-over-quarter to $11.2B.

Based on Boston Trust Walden's 13F filing for Q2 2021, filed 22 Jul 2021.